Store-operated Ca 2+ influx represents a major route by which cytosolic Ca 2+ can be elevated during platelet activation, yet its molecular identity in this cell type remains highly controversial. Using quantitative RT-PCR analysis of candidate receptor-operated cation entry pathways in human platelets, we show a >30-fold higher expression of message for the recently discovered Orai1 store-operated Ca 2+ channel, and also the store Ca 2+ sensor STIM1, when compared to the non-selective cation channels TRPC1, TRPC6 and TRPM2. Orai1 and STIM1 gene transcripts were also detected at higher levels than TRPC1, TRPC6 and TRPM2 in primary murine megakaryocytes and human megakaryocytic cell lines. In direct electrophysiological recordings from murine megakaryocytes, Ca 2+ ionophore-induced store depletion stimulated CRAC currents, which are known to require Orai1, and these overlapped with TRPC6-like currents following P2Y receptor activation. Together with recent transgenic studies, these data provide evidence for STIM1:Orai1 as a primary pathway for agonist-evoked Ca 2+ influx in the platelet and megakaryocyte.
Introduction
Ca 2+ mobilisation pathways are potentially important anti-thrombotic targets due to the key role of receptor-mediated cytosolic Ca 2+ increases ([Ca 2+ ] i ) in platelet activation [1] . It is well established that IP 3 -dependent Ca 2+ release represents a central pathway for mobilising Ca 2+ downstream of both G-protein-coupled and tyrosine kinase-linked surface receptors [2] . In addition, parallel activation of plasma membrane cation channels can sustain and amplify agonist-evoked [Ca 2+ ] i responses due to the comparatively infinite content of the extracellular versus intracellular Ca 2+ pools. The platelet expresses one ligand-gated nonselective cation channel, the P2X 1 receptor, which can contribute to Ca 2+ entry following stimulation by ATP released from damaged vasculature or secreted from platelet granules [3] . However, the molecular nature of other receptor-operated Ca 2+ entry pathways, particularly that activated by depletion of internal stores [4;5] , remains highly controversial [4;6] . Members of the canonical transient receptor potential family of ion channels (TRPC) represent prime candidates for Ca 2+ influx pathways stimulated by products of phospholipase-C, and most groups agree that platelets and megakaryocytes express TRPC1 and TRPC6 [6] [7] [8] . In addition, megakaryocytes possess TRPM2, a member of the melanostatin family of TRP channels, which may contribute to Ca 2+ influx during haemostasis and thrombosis since activated platelets are known to generate superoxide, an endogenous ligand of the channel [9;10] .
Recent seminal work by several groups has shown that store-dependent Ca 2+ influx in various non-excitable cell types occurs by coupling of the intracellular store Ca 2+ sensor STIM1 (stromal interaction molecule 1) [11] [12] [13] to plasma membrane CRAC channels, of which Orai1 (also known as CRACM1) forms an essential component [14] [15] [16] . Emerging evidence indicates an important role for STIM1 in platelet function as heterozygote mice carrying an activating point mutation in the EF-hand motif of STIM1 display premature platelet activation, leading to accelerated platelet consumption and macrothrombocytopenia [17] . To date, TRPC1 is the only ion channel suggested to couple STIM1 to store-dependent Ca 2+ entry in the platelet [18] . Surprisingly, however, TRPC1-deficient mice show no platelet-related phenotype [19] . We have therefore used quantitative RT-PCR to examine the relative expression of STIM1, Orai1 and TRP channels that may contribute to receptoroperated Ca 2+ influx in the platelet. Evidence from human platelets, primary murine megakaryocytes and human megakaryocytic cell lines strongly support the hypothesis that STIM1-coupled Orai1 channels contribute to store-operated Ca 2+ entry in this cell type.
Methods

Cell preparation
Human platelets were isolated as described elsewhere [20] . Briefly, 100 ml blood was collected from each donor by self-propagated flow through a Venflon™ IV cannula (diameter: 1.2 mm; BD, NJ, USA) into 10 ml Falcon tubes containing 1.5 ml citratedextrose solution (Sigma product no C3821), 2 mM EDTA, 0.1 μM PGE 1 and 0.3 mM aspirin (all from Sigma, MO, USA). The project was approved by the Ethics Committee of Lund University, Sweden and all blood donors gave written informed consent to participate in the study. Platelet rich plasma (PRP) was obtained by centrifugation for 20 min at 200 g min followed by 10 min at 200 g and passed through a Pall AutoStop™ Leukocyte removal filter (Pall Inc., NY, USA). The platelet filtrates were leukocyte-and erythrocyte-depleted using anti-CD235a and anti-CD45-coated magnetic Dynabeads (BD Inc. NJ, USA and Dynal, Oslo, Norway) according to the manufacturer's instructions. The purified platelets were collected by centrifugation (10 min, 800 g), dissolved in 4 ml TRIzol® (Invitrogen, CA, USA) and stored at -85 °C until RNA isolation. The megakaryocytic cell lines HEL and MEG-01 were obtained from the European Collection of Cell Cultures (ECACC, Porton Down, Salisbury, UK) and cultured in RPMI 1640, supplemented with 10% fetal calf serum, 100 units ml -1 penicillin and 100 μg ml -1 streptomycin in a humidified atmosphere at 37°C with 5% CO 2 . Primary murine megakaryocytes from the tibial and femoral marrow of adult C57/Bl6 mice were prepared for electrophysiological experiments and selected individually using glass micropipettes for RT-PCR studies as previously described [8] . 35 individual megakaryocytes were combined for each reverse transcription reaction, which was subsequently diluted for PCR reactions.
Reagents and solutions
The standard external saline used for isolating megakaryocytes for electrophysiological experiments contained (in mM) 145 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 10 D-glucose and 10 HEPES, pH 7.35 (NaOH). For electrophysiological recordings, salines were designed to eliminate K + -selective membrane currents; thus, KCl in the external saline was replaced with an equal concentration of NaCl and the K + channel blocker 4-aminopyridine (2 mM) was present throughout. For normal intracellular Ca 2+ buffering conditions, the pipette saline contained (in mM) 150 CsCl, 2 MgCl 2 , 0.05 Na 2 GTP, 0.05 K 5 Fura-2, 10 Hepes, 0.1 EGTA, pH 7.2 (CsOH). For high internal Ca 2+ buffering, the pipette saline contained (in mM) 120 CsCl, 2 CaCl 2 , 2 MgCl 2 , 0.05 Na 2 GTP, 0.05 K 5 Fura-2, 10 Hepes, 10 Cs 4 BAPTA, pH 7.2 (CsOH). K 5 Fura-2 and Cs 4 BAPTA were supplied by Molecular Probes (Leiden, The Netherlands). Applied Biosystems (Warrington, UK) supplied all real-time PCR reagents, whilst Qiagen Ltd (Crawley, UK) supplied all other molecular reagents and kits, unless otherwise stated. Cell culture reagents were supplied by Gibco (Paisley, UK). All other reagents were supplied by Sigma-Aldrich (Poole, UK).
RT-PCR
Total RNA and cDNA were prepared from individually extracted megakaryocytes as previously described [8] . Total RNA was extracted from platelets using a modified TRIzol protocol as described elsewhere [20] . Platelet cDNA was generated using random hexamer priming and TaqMan® Reverse transcription (Applied Biosystems, CA, USA) according to the manufacturer's instructions. The extremely low grade of leukocyte contamination was confirmed through quantitative real-time PCR using leukocyte-common antigen (CD45) as a marker of leukocyte contamination, as described elsewhere [20] . Total RNA was purified from cultured cell lines using the RNeasy® mini kit and reverse-transcribed using the High Capacity cDNA RT kit with RNasin® inhibitor according to the manufacturer's instructions (Promega, Southampton, UK). Relative quantification of gene targets was performed using the Applied Biosystems 7500 Real Time system. For each target and housekeeping gene, 
Electrophysiology
Conventional whole-cell patch clamp recordings were carried out using an Axopatch 200B amplifier (Axon CNS Molecular Devices Corporation, Union City, CA, USA) in voltage clamp mode as described in detail elsewhere [21] . Current-voltage relationships of membrane conductances were assessed using voltage ramps of 100 msec duration from a holding potential of -70 mV to a peak of +70 mV. Membrane currents during voltage ramps were filtered at 1 kHz and acquired at a rate of 5 kHz, using a Digidata 1200 A/D converter and pClamp 6 (Axon CNS Molecular Device Corporation). Membrane currents were also digitized at a slower rate (60 Hz, filtered at 30 Hz) using a Cairn Research Ltd (Faversham, Kent) acquisition system to provide a continuous recording of holding current. All experiments were carried out at room temperature. Data were analysed using Clampfit v9.0 (Axon Instruments) or Cairn Research Ltd software and exported for presentation in Microcal Origin (Microcal Software Inc, Northampton, MA, USA).
Results and Discussion
A recent RT-PCR screen of all known transient receptor potential ion channels within primary murine megakaryocytes demonstrated the presence of messages for TRPC1, TRPC6, TRPM1, TRPM2 and TRPM7 [8] . Of these, TRPC1, TRPC6 and TRPM2 have been proposed to contribute to agonist-evoked Ca 2+ signalling in the platelet via storeoperated, store-independent or secondary superoxide-dependent mechanisms, respectively. However, Orai1, a transmembrane protein shown to be essential for store-operated Ca 2+ influx through CRAC channels, has not been demonstrated in platelets or megakaryocytes. Using material from individually selected megakaryoctyes, a strong signal was obtained for Orai1 using qRT-PCR, and the relative gene expression for the different Ca 2+ -permeable ion channels displayed the order: Orai1>TRPC1>TRPC6>TRPM2 (Fig. 1A) . In addition, the transcript for STIM1, the Ca 2+ store sensor required for activation of CRAC channels showed a high relative expression in the megakaryocyte. Grosse et al. [17] have also recently shown, using immunohistochemical studies, that STIM1 is highly expressed in murine marrow megakaryocytes. Orai1 and STIM1 gene transcripts were also detected in human platelets at significantly higher levels than TRPC1, TRPC6 and TRPM2 (Fig. 1B) . The ratio of Orai1 expression to that of TRPC1 and TRPC6 in the platelet was 36 and 32 fold, respectively. Finally, two human megakaryocytic cell lines, HEL and MEG-01 showed a clear gene expression for STIM1 and Orai1, with a smaller relative signal for TRPC1, whereas TRPC6 or TRPM2 were not detected (Fig. 1C) . Taken together, these data demonstrate for the first time a strong expression of Orai1, an essential component of the store-operated CRAC channel [22] [23] [24] , in the platelet and megakaryocyte. The gene for STIM1, the Ca 2+ sensor required for activation of this channel upon store depletion, is also strongly expressed in the platelet and megakaryocyte Although CRAC currents have been reported in HEL cells and rat megakaryocytes [25, 26] , this Ca 2+ influx pathway has not been shown in murine megakaryocytes or platelets. Attempts to record store-dependent CRAC currents in thapsigargin-treated human platelets suggested that the underlying channel is below the limit of resolution of the patch clamp technique (Martyn Mahaut-Smith, unpublished observations). This may result from the low current density of this highly Ca 2+ -selective conductance and the small capacitance of the platelet (≈130 fF; [27] ). We therefore further examined the agonist-and store-dependent ionic conductances in the primary murine megakaryocyte, which we and other groups have argued represents a valid model for studies of signalling in the anuclear platelet [28;29] . For example, the unique synergy between G q and G i -coupled receptors, leading to inside-out activation of α IIb β 3 receptors that is crucial for platelet function, is well established in the mature megakaryocyte [28;30] . The primary murine megakaryocyte also has the advantage that recent work has electrophysiologically characterised the non-selective cation influx currents coupled to P2Y receptor activation [8;28] . Selective activation of store-dependent over store-independent inward currents was achieved by depletion of intracellular Ca 2+ stores with the ionophore ionomycin under high intracellular Ca 2+ buffering conditions [31] . This induced, over a period of tens of seconds, a sustained inward current (Fig. 2Ai) with a pronounced inwardly rectifying current-voltage relationship (Fig. 2Aii) , typical of CRAC currents recorded in HEL cells, rat megakaryocytes and other non-excitable cell types, including RBL cells and lymphocytes [25;26;31-33] . The very positive reversal potential for this conductance is indicative of a high selectivity for divalent cations. When the pipette saline contained low Ca 2+ buffering levels (0.1 mM EGTA), the physiological agonist ADP activated an initial transient current which subsided into a smaller sustained event (Fig. 2Bi) , as previously reported [8;28] . This ADP-evoked conductance exhibits a curvilinear relationship, with pronounced outward rectification and a reversal potential near 0mV (Fig.  2Bii) due to its non-selective permeability to cations [8;28] . Based on these characteristics and potentiation by flufenamic acid (FlFnA), we have recently concluded that the majority of the ADP-evoked current is carried through TRPC6, since FlFnA blocks other TRPC channels [8] . Transient currents through autocrine activation of P2X 1 receptors are also variably observed during the plateau phase [28] , although recordings in which such events were infrequent were used for the present study. I CRAC would also be expected to be activated by ADP, but will be masked by TRPC6 due to the small magnitude of the storedependent CRAC current at pseudophysiological Ca 2+ buffering levels [25;31;32] . Increasing the Ca 2+ buffering power led to a more sustained initial ADP-evoked inward current (Fig. 2Ci) , with a current-voltage relationship that represents a combination of Fig.  2Aii and Fig.2Bii , and a reversal potential part-way between that of TRPC6 and I CRAC (Fig.  2Cii) . We do not at present understand why the ADP-evoked current was not as maintained as observed with ionomycin, but one possibility is that this results from part-inactivation of CRAC currents due to partial store refilling, which can occur during agonist stimulation after the initial burst of IP and Ca 2+ release. Taken together, these data suggest that physiological agonists will evoke Ca 2+ influx through a combination of TRPC6 and CRAC channels. We cannot at present rule out a role for TRPC1, although TRPC1-deficient mice show no significant platelet-related phenotype and thus this channel is not essential for normal platelet function [19] . Further support for a lack of major role for TRPC1 comes from work on megakaryocytic cell lines. TRPC1, but not TRPC6, was detected in HEL and MEG-01 cells lines (Fig. 1C) and a previous study found evidence only for CRAC currents during stimulation by thrombin and store depletion [26] . The importance of TRPM2 in agonist-evoked Ca 2+ entry remains to be investigated.
Although CRAC currents are small at normal levels of intracellular Ca 2+ buffering, the high selectivity of the channel for Ca 2+ under physiological conditions, even over Mg 2+ , allows significant Ca 2+ influx [31] [32] [33] . Given the high surface area:volume ratio of the platelet, this pathway will efficiently elevate cytosolic Ca 2+ , a key signal during platelet activation [1] . Indeed, homozygote mice with an activating point mutation in the EF hand of STIM1 show severe haemorrhaging and exhibit embryonic lethality [17] . The platelets (and T lymphocytes) from heterozygote mice carrying this mutation have elevated basal intracellular Ca 2+ concentrations and enhanced background Ca 2+ influx, consistent with a role for STIM1 in the calcium entry pathway of these cells. Intracellular Ca 2+ increases and functional responses resulting from stimulation of platelet PLCγ-coupled receptors (GPVI and CLEC-2) were compromised, whereas, unexpectedly, signalling via a number of PLCβ-coupled receptors showed no defects. The reasons for the effect on PLCγ rather than PLCβ-coupled receptor responses is unclear, however STIM1 may have other unrecognised roles in platelet function and further studies are required, particularly selective downregulation of STIM and Orai expression in the platelet/megakaryocyte lineage. Nevertheless, a case is emerging for a major role for STIM1 activation of Orai1 in Ca 2+ signalling within the platelet and megakaryocyte. This prototypical store-dependent Ca 2+ influx pathway may therefore serve as a clinical means to modulate thrombopoiesis and platelet function. 
